Naltrexone XR May Be Associated With Dysphoria, Suicide Ideation
Monthly injections of naltrexone extended-release may induce a dysphoric state and suicidal ideation in some patients.
All articles by Clinical Pain Advisor Contributing Writer
Broader Medicaid Eligibility May Be a Tool for Reducing Substance Use Disorder-Related Deaths
Expanded Medicaid eligibility thresholds were associated with a reduction in substance use disorder-related deaths during the current US opioid epidemic.
Influence of Medical Malpractice on Shared Decision-Making Simulations
Researchers recently performed a simulation study to determine how 3 levels of shared decision making can increase the chances of patients suing for adverse outcomes.
Classical Music-Based Interventions for Chronic Pain
Exposure to certain classical music pieces may have an analgesic effect in a mouse model of inflammatory pain and be associated with reduced allodynia in a mouse model of surgical pain.
Quality Improvement Strategies Benefit Care Delivery in Pediatric Headache
Although it may be difficult to demonstrate improved patient outcomes, quality improvement efforts using team-based strategies and electronic medical record integration can improve performance on headache quality measures.
Patients With Migraine Value Favorable Drug Delivery, Efficacy, Tolerability
Patients with migraine prefer preventive migraine treatments that have improved efficacy, greater tolerability, and lower risk for adverse events (AE), according to a study published in Headache. Investigators analyzed a web-based discrete-choice experiment survey to find patients’ preferences for preventive migraine treatment. Patients with migraine (N=300) were asked to choose between pairs of hypothetical preventive…
Best Practices for the Ethical Use of Nanosensors in Employee Surveillance
The authors explain 5 best practices to encourage nano-enabled worker monitoring programs that are acceptable, effective, and ethical.
Propranolol Associated With Decreased Headache Frequency
Researchers found data indicating that propranolol reduces episodic migraine headaches from 5 to 3 per month.
Decreased Response to Botulinum Toxin Type A Agents Observed Over Time
Preliminary findings showed the decrease in botulinum toxin type A therapeutic effect over time warrants further study.
Use by Paramedics of Intranasal Ketamine Plus Nitrous Oxide May Alleviate Acute Pain
The addition of intranasal ketamine, administered by paramedics, to usual treatment with nitrous oxide was found to alleviate acute pain and improve comfort within 30 minutes.
Next post in Acute Pain
